These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
325 related articles for article (PubMed ID: 16874755)
1. Ropinirole is effective in the long-term management of restless legs syndrome: a randomized controlled trial. Montplaisir J; Karrasch J; Haan J; Volc D Mov Disord; 2006 Oct; 21(10):1627-35. PubMed ID: 16874755 [TBL] [Abstract][Full Text] [Related]
2. Ropinirole is effective in the treatment of restless legs syndrome. TREAT RLS 2: a 12-week, double-blind, randomized, parallel-group, placebo-controlled study. Walters AS; Ondo WG; Dreykluft T; Grunstein R; Lee D; Sethi K; Mov Disord; 2004 Dec; 19(12):1414-23. PubMed ID: 15390050 [TBL] [Abstract][Full Text] [Related]
3. A 52-week open-label study of the long-term safety of ropinirole in patients with restless legs syndrome. Garcia-Borreguero D; Grunstein R; Sridhar G; Dreykluft T; Montagna P; Dom R; Lainey E; Moorat A; Roberts J Sleep Med; 2007 Nov; 8(7-8):742-52. PubMed ID: 17512789 [TBL] [Abstract][Full Text] [Related]
4. Efficacy and tolerability of ropinirole in patients with restless legs syndrome and a baseline IRLS total score > or = 24 points--data from the ropinirole clinical trial programme. Giorgi L; Ritchie SY; Kirsch JM Curr Med Res Opin; 2006 Oct; 22(10):1867-77. PubMed ID: 17022844 [TBL] [Abstract][Full Text] [Related]
5. Ropinirole in patients with restless legs syndrome and baseline IRLS total scores ≥ 24: efficacy and tolerability in a 26-week, double-blind, parallel-group, placebo-controlled study followed by a 40-week open-label extension. Giorgi L; Asgharian A; Hunter B Clin Ther; 2013 Sep; 35(9):1321-36. PubMed ID: 23938061 [TBL] [Abstract][Full Text] [Related]
7. Clinical efficacy of ropinirole for restless legs syndrome is not affected by age at symptom onset. Allen RP; Ritchie SY Sleep Med; 2008 Dec; 9(8):899-902. PubMed ID: 18024167 [TBL] [Abstract][Full Text] [Related]
9. Meta-analysis of the efficacy and tolerability of pramipexole versus ropinirole in the treatment of restless legs syndrome. Quilici S; Abrams KR; Nicolas A; Martin M; Petit C; Lleu PL; Finnern HW Sleep Med; 2008 Oct; 9(7):715-26. PubMed ID: 18226947 [TBL] [Abstract][Full Text] [Related]
10. Patient- and physician-rated measures demonstrate the effectiveness of ropinirole in the treatment of restless legs syndrome. Kushida CA; Geyer J; Tolson JM; Asgharian A Clin Neuropharmacol; 2008; 31(5):281-6. PubMed ID: 18836346 [TBL] [Abstract][Full Text] [Related]
11. Effect of pramipexole on RLS symptoms and sleep: a randomized, double-blind, placebo-controlled trial. Ferini-Strambi L; Aarskog D; Partinen M; Chaudhuri KR; Sohr M; Verri D; Albrecht S Sleep Med; 2008 Dec; 9(8):874-81. PubMed ID: 18952497 [TBL] [Abstract][Full Text] [Related]
12. Ropinirole in the treatment of restless legs syndrome: results from the TREAT RLS 1 study, a 12 week, randomised, placebo controlled study in 10 European countries. Trenkwalder C; Garcia-Borreguero D; Montagna P; Lainey E; de Weerd AW; Tidswell P; Saletu-Zyhlarz G; Telstad W; Ferini-Strambi L; J Neurol Neurosurg Psychiatry; 2004 Jan; 75(1):92-7. PubMed ID: 14707315 [TBL] [Abstract][Full Text] [Related]
13. Long-term open-label study of pramipexole in patients with primary restless legs syndrome. Inoue Y; Kuroda K; Hirata K; Uchimura N; Kagimura T; Shimizu T J Neurol Sci; 2010 Jul; 294(1-2):62-6. PubMed ID: 20451927 [TBL] [Abstract][Full Text] [Related]
14. Open-label study of the long-term efficacy and safety of pramipexole in patients with Restless Legs Syndrome (extension of the PRELUDE study). Partinen M; Hirvonen K; Jama L; Alakuijala A; Hublin C; Tamminen I; Koester J; Reess J Sleep Med; 2008 Jul; 9(5):537-41. PubMed ID: 18276187 [TBL] [Abstract][Full Text] [Related]
15. Efficacy and safety of pramipexole in Japanese patients with primary restless legs syndrome: A polysomnographic randomized, double-blind, placebo-controlled study. Inoue Y; Hirata K; Kuroda K; Fujita M; Shimizu T; Emura N; Uchimura N; Kagimura T; Sha K; Nozawa T Sleep Med; 2010 Jan; 11(1):11-6. PubMed ID: 19962941 [TBL] [Abstract][Full Text] [Related]
16. An exploratory retrospective evaluation of ropinirole-associated psychotic symptoms in an outpatient population treated for restless legs syndrome or Parkinson's disease. Stoner SC; Dahmen MM; Makos M; Lea JW; Carver LJ; Rasu RS Ann Pharmacother; 2009 Sep; 43(9):1426-32. PubMed ID: 19690226 [TBL] [Abstract][Full Text] [Related]